HeartLight X3 Endoscopic Ablation System With Excalibur Balloon for Treatment of Symptomatic Persistent AF

Last updated: July 19, 2021
Sponsor: CardioFocus
Overall Status: Completed

Phase

N/A

Condition

Chest Pain

Arrhythmia

Atrial Fibrillation

Treatment

N/A

Clinical Study ID

NCT03988244
25-4911
  • Ages 18-75
  • All Genders

Study Summary

The objective of the study is to demonstrate the improved ablation and procedure times of the HeartLight X3 compared to the original HeartLight catheter in the treatment of persistent atrial fibrillation.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • early persistent AF, failure of at least one AAD, others

Exclusion

Exclusion Criteria:

  • overall good health as established by multiple criteria

Study Design

Total Participants: 11
Study Start date:
February 26, 2019
Estimated Completion Date:
April 03, 2020

Connect with a study center

  • Nemocnice Na Homolce

    Prague,
    Czechia

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.